OXON helps clients to identify and fill in the data gaps for their products in the pre-and post approval phases.
We work with clients, based on their strategy, using the appropriate components illustrated bellow:
We provide the highest quality appropriate interpretation presented apropriately for the target audience.
We help decision making for clients in development and post-marketing phases by building appropriate decision models.
Our expertise of the review, synthesis and integration of data and information is of the highest standard:
Senior members of OXON have co-authored (x7) Lancet, (x1) JAMA and (x3) BMJ publications of individual-participant and grouped data meta-analyses of epidemiological studies and trials
A senior member of OXON was the founding co-ordinating editor of the Cochrane Dementia Group
A senior member of OXON is chief editor of the international clinical textbook 'Evidence-based Dementia Practice'. published by Blackwells, Oxford. We are leading an initiative in ENCePP at the EMA on data integration, the first task of which will be a guidance document on the conduct of data integration of observational studies, with leading academic epidemiologists and regulators in Europe.
Expertise in epidemiology and trials and meta-analysis
We have published in the top medical major journals ((x7) Lancet, (x1) JAMA and (x3) BMJ), led a Cochrane group, have an honorary senior lecturer in epidemiology at Imperial College, London University, and are currently leading an initiative at the EMA on data integration for safety
Expertise in statistics:
We have analysed epidemiological, trials, safety, PRO, health economic data. We have access to academic statisticians in Cambridge and London (a world renowned medical statistician) as consultants.
Clinical (and patient-reported outcomes) expertise:
We have an Oxford trained honorary consultant geriatrician and a patient-reported outcomes researcher, rapid access to practising hospital clinical consultants in a range of therapeutic areas and also an Oxford professor of patient reported outcomes as a consultant.
We have a former head of PV at Schering-Plough, have contacts at the EMA and also a former Director of the WHO Drug Monitoring Centre and member of CIOMS acts as a consultant.
Knowledge of industry
Members of OXON have previously worked in big pharma at varying levels of seniority (SB, GSK, Pfizer, Pharmacia, AstraZeneca, Schering-Pough) and have an intimate knowledge of the workings of industry, which they bring to bear in finding solutions for clients.
Copyright © 2013 Oxon All Rights Reserved - Late phase CRO